Recent reports claim that short-term pharmacological Cpt1 inhibition improves skeletal muscle glucose tolerance and insulin sensitivity. and insulin actions. Recently published reviews have got highlighted pharmacological Cpt1 inhibitors, etomoxir and oxfenicine, as therapies for enhancing blood sugar tolerance (1, 2). In comparison to fat rich diet given controls, mice implemented oxfenicine screen attenuated diet-induced elevations… Continue reading Recent reports claim that short-term pharmacological Cpt1 inhibition improves skeletal muscle